Osaic Holdings’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $65.1K | Sell |
96,852
-400
| -0.4% | -$269 | ﹤0.01% | 4503 |
|
|
2025
Q1 | $43.8K | Buy |
97,252
+40,516
| +71% | +$18.3K | ﹤0.01% | 4801 |
|
|
2024
Q4 | $28.4K | Sell |
56,736
-7,315
| -11% | -$3.66K | ﹤0.01% | 5079 |
|
|
2024
Q3 | $58.1K | Buy |
64,051
+16,912
| +36% | +$15.3K | ﹤0.01% | 4620 |
|
|
2024
Q2 | $47K | Buy |
47,139
+45,052
| +2,159% | +$44.9K | ﹤0.01% | 4702 |
|
|
2024
Q1 | $3.09K | Sell |
2,087
-106
| -5% | -$157 | ﹤0.01% | 6166 |
|
|
2023
Q4 | $2.39K | Sell |
2,193
-44,178
| -95% | -$48.1K | ﹤0.01% | 6361 |
|
|
2023
Q3 | $54.7K | Sell |
46,371
-394
| -0.8% | -$465 | ﹤0.01% | 4935 |
|
|
2023
Q2 | $65.9K | Buy |
46,765
+81
| +0.2% | +$114 | ﹤0.01% | 4748 |
|
|
2023
Q1 | $70K | Hold |
46,684
| – | – | ﹤0.01% | 4727 |
|
|
2022
Q4 | $54.9K | Buy |
46,684
+44,400
| +1,944% | +$52.3K | ﹤0.01% | 4858 |
|
|
2022
Q3 | $2K | Hold |
2,284
| – | – | ﹤0.01% | 6708 |
|
|
2022
Q2 | $3K | Hold |
2,284
| – | – | ﹤0.01% | 6675 |
|
|
2022
Q1 | $3K | Hold |
2,284
| – | – | ﹤0.01% | 6619 |
|
|
2021
Q4 | $5K | Sell |
2,284
-89
| -4% | -$195 | ﹤0.01% | 6534 |
|
|
2021
Q3 | $6K | Sell |
2,373
-400
| -14% | -$1.01K | ﹤0.01% | 6422 |
|
|
2021
Q2 | $13K | Sell |
2,773
-3,123
| -53% | -$14.6K | ﹤0.01% | 5889 |
|
|
2021
Q1 | $13K | Buy |
5,896
+3,580
| +155% | +$7.89K | ﹤0.01% | 5706 |
|
|
2020
Q4 | $4K | Sell |
2,316
-698
| -23% | -$1.21K | ﹤0.01% | 5786 |
|
|
2020
Q3 | $3K | Buy |
3,014
+19
| +0.6% | +$19 | ﹤0.01% | 5675 |
|
|
2020
Q2 | $2K | Buy |
2,995
+134
| +5% | +$89 | ﹤0.01% | 5719 |
|
|
2020
Q1 | $2K | Buy |
+2,861
| New | +$2K | ﹤0.01% | 5602 |
|